Latest From Thrombologic APS
Brief profiles of these recently formed companies: LipimetiX, Nautilus Neurosciences, SpineGuard and Thrombologic.
In Vivo briefly describes these recently founded companies: Avraham Pharmaceuticals, LipimetiX, Nautilus Neurosciences, NovaTract Surgical, SpineGuard and Thrombologic.
Brief summaries of recent clinical developments in the device industry, including cell therapy for arrhythmias, hospitalization for young diabetics, cooling to save trauma patients, cell regeneration in the intestine, and lack of efficacy for popular osteoarthritis treatments.
At the 2007 annual meeting of the Radiological Society of North America in November, the sparkle of new innovations was tarnished somewhat by questions about the rapid proliferation of advanced imaging technologies and their cost effectiveness. As a result both new and old technologies are facing an uphill battle to prove their worth in a heavily scrutinized economic environment.
- Therapeutic Areas
- Immune Disorders
- Infectious & Viral Diseases
- Western Europe
- Parent & Subsidiaries
- Thrombologic APS
- Senior Management
- Karolina Rask, CEO
- Contact Info
Phone: (45) 3534 0112
COBIS / Ole Maaløesvej 3
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.